Centre Jean Bernard, Clinique Victor Hugo

Le Mans 72015

0 studies enrolling now · 8 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Castration-resistant Prostate Cancer, Chronic Lymphocytic Leukemia, Lymphoma, Follicular, Multiple Myeloma, Neoplasm Metastasis, Prostate Cancer, Prostate Cancer Metastatic, Relapsed and/or Refractory Multiple Myeloma, Urinary Bladder Neoplasm

Studies at this site

• HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Stopped early
• A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM — Stopped early
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study) — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed
• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed